Implant Survival After Surgical Treatment of Peri-implantitis of Infra-bony Defects
Bony defects
Implant Survival After Reconstructive Surgical Therapy of Peri-implantitis-related Bone Defects With Different Defect Configurations
1 other identifier
observational
75
1 country
1
Brief Summary
To report the 10 years outcomes of a reconstructive surgical protocol for peri-implantitis defects with different morphologies, by means of deproteinized bovine bone mineral with 10% collagen (DBBMC).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
CompletedFirst Posted
Study publicly available on registry
September 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
September 9, 2026
September 1, 2026
10 months
August 24, 2026
September 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Implant survival rate
Clinical Examination: Number of implants treated for peri-implantitis present in the oral cavity at the latest follow-up over the overall number of implants treated, expressed in %
From enrollment to the end of treatment at the 10-year follow-up visit
Implant survival rate
Percentage of implants still in place after surgical intervention
10-year
Study Arms (1)
Patients rehabilitated with a dental implants affected by a crater-like defect
Subjects, who presented a single peri-implantitis crater-like lesion with a PD of ≥6 mm and no implant mobility. Exclusion criteria were as follows: 1. PD \<6 mm; 2. Class II defects (characterized by consistent horizontal bone loss); 3. Multiple defects; 4. Implant mobility; 5. No interest in participating in the study; 6. Implants placed by other clinicians.
Interventions
Intervention: Following the elevation of a muco-periosteal flap, all granulation tissue was completely removed from the defect area, by means of titanium curettes and a titanium brush under irrigation. Consequently, implant surfaces were covered with EDTA 24% for 2 min and chlorhexidine 1% gel for 2 min. Thereafter, the infrabony defects were filled with a deproteinized bovine bone mineral with 10% collagen. All patients were asked to follow an individualized supportive care program.
Eligibility Criteria
Subjects rehabilitated with oral dental implants who presented a single peri-implantitis crater-like lesion with a PD of ≥6 mm
You may qualify if:
- Patients rehabilitated with oral dental implants affected by peri-implantitis
- A single peri-implantitis crater-like lesion with a Probing depth ofof ≥6 mm
- No implant mobility,
- Smokers
You may not qualify if:
- Probing depth \<6 mm;
- Class II defects (characterized by consistent horizontal bone loss);
- Multiple defects;
- Implant mobility;
- Subjects not interested in participating in the study;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
S.C. Chirurgia Maxillo-facciale U
Torino, Italy
Related Publications (1)
Roccuzzo M, Mirra D, Pittoni D, Ramieri G, Roccuzzo A. Reconstructive treatment of peri-implantitis infrabony defects of various configurations: 5-year survival and success. Clin Oral Implants Res. 2021 Oct;32(10):1209-1217. doi: 10.1111/clr.13818. Epub 2021 Aug 16.
PMID: 34352140RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2026
First Posted
September 9, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
September 9, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share